10 Hedge Funds Betting Against Cathie Wood’s ARK Innovation ETF
In this article, we discuss the 10 hedge funds that are betting against Cathie Wood’s ARK Innovation ETF.
Posts Tagged ‘Cormorant Asset Management’
Hedge Fund and Insider Trading News: Alan Howard, Ray Dalio, RIT Capital Partners, Alphadyne Asset Management, Archegos Capital Management, Cormorant Asset Management, Immuneering Corp (IMRX), Wingstop Inc (WING), and More
Alan Howard, the co-founder of macro hedge fund Brevan Howard, has invested in German crypto asset manager Iconic Holding, according to the shareholder list of the German Handelsregister...
Three Biotech Investment Ideas from Cormorant Asset Management
The biotech industry is regaining ground it lost in 2016 at full speed.
13G Filing: Cormorant Asset Management and Ignyta Inc. (RXDX)
Please follow Cormorant Asset Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Cormorant Asset Management or update...
13G Filing: Cormorant Asset Management and Trillium Therapeutics Inc. (TRIL)
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent...
Sunesis Pharmaceuticals Inc (SNSS): Cormorant Asset Management Reports New 5.14% Stake
Sunesis Pharmaceuticals Inc (NASDAQ:SNSS) has a new shareholder in the form of Bihua Chen's Cormorant Asset Management.
Myokardia Inc (MYOK): Cormorant Asset Management Raises Its Stake
A recent 13G filing with the Securities and Exchange Commission revealed that Bihua Chen's Cormorant Asset Management has boosted its stake in Myokardia Inc (NASDAQ:MYOK) to ...
Cormorant Asset Management Doesn’t Think Corbus Pharmaceuticals Holdings Inc. (CRBP) Is Done Soaring Just Yet
In a new 13G filing with the SEC, Bihua Chen's Cormorant Asset Management reported owning 2.35 million shares of Corbus Pharmaceuticals Holdings Inc.
Gemphire Therapeutics Inc. (GEMP): Cormorant Asset Management Reports New Stake
According to a new 13G filing with the Securities and Exchange Commission, Bihua Chen's Cormorant Asset Management owns 900,000 shares of Gemphire Therapeutics Inc.
Clearside Biomedical Inc (CLSD): Cormorant Reveals 10.1% Stake
Bihua Chen's Cormorant Asset Management has revealed a position in Clearside Biomedical Inc (NASDAQ:CLSD), through a 13G filing issued with the SEC yesterday.
Quotient Ltd (QTNT): Bihua Chen’s New Fund, Cormorant Asset Management, Triples Stake
Bihua Chen’s Cormorant Asset Management disclosed, last Thursday, that it had tripled its exposure to Quotient Ltd (NASDAQ:QTNT), from 500,000 shares held by the end of the ...
